{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T07:52:29Z","timestamp":1750405949788,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1245\/s10434-022-12684-w","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T15:10:05Z","timestamp":1666710605000},"page":"830-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6116-6376","authenticated-orcid":false,"given":"Shunsuke","family":"Shigefuku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"1","key":"12684_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"12684_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jtho.2017.12.010","volume":"13","author":"KA Houston","year":"2018","unstructured":"Houston KA, Mitchell KA, King J, et al. Histologic lung cancer incidence rates and trends vary by race\/ethnicity and residential county. J Thorac Oncol. 2018;13(4):497\u2013509.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"12684_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jtcvs.2013.09.065","volume":"147","author":"NK Altorki","year":"2014","unstructured":"Altorki NK, Yip R, Hanaoka T, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147(2):754\u201362 (Discussion 762\u2013754).","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"12684_CR4","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.jtcvs.2021.06.056","volume":"163","author":"MK Kamel","year":"2021","unstructured":"Kamel MK, Lee B, Harrison SW, et al. Sublobar resection is comparable to lobectomy for screen-detected lung cancer. J Thorac Cardiovasc Surg. 2021;163(6):1907\u201315.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10335","key":"12684_CR5","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","volume":"399","author":"H Saji","year":"2022","unstructured":"Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607\u201317.","journal-title":"Lancet"},{"issue":"3","key":"12684_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/icvts\/ivt500","volume":"18","author":"A Hattori","year":"2014","unstructured":"Hattori A, Suzuki K, Matsunaga T, et al. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan. Interact Cardiovasc Thorac Surg. 2014;18(3):329\u201334.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"12684_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lungcan.2014.11.010","volume":"87","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Saji H, Shinmyo T, et al. Close association of IASLC\/ATS\/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer. 2015;87(1):28\u201333.","journal-title":"Lung Cancer"},{"issue":"1","key":"12684_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project. J Thorac Oncol. 2008;3(1):6\u201312.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"12684_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jtcvs.2011.02.007","volume":"141","author":"M Okada","year":"2011","unstructured":"Okada M, Nakayama H, Okumura S, et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography\/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141(6):1384\u201391.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"12684_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243\u201360.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"12684_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"12684_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/14737159.2017.1288568","volume":"17","author":"U Malapelle","year":"2017","unstructured":"Malapelle U, Sirera R, Jantus-Lewintre E, et al. Profile of the Roche cobas EGFR mutation test v2 for non-small cell lung cancer. Expert Rev Mol Diagn. 2017;17(3):209\u201315.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"12684_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2353\/jmoldx.2006.060030","volume":"8","author":"S Matsukuma","year":"2006","unstructured":"Matsukuma S, Yoshihara M, Kasai F, et al. Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay. J Mol Diagn. 2006;8(4):504\u201312.","journal-title":"J Mol Diagn"},{"issue":"9","key":"12684_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/00006231-200209000-00010","volume":"23","author":"HJ Jeong","year":"2002","unstructured":"Jeong HJ, Min JJ, Park JM, et al. Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun. 2002;23(9):865\u201370.","journal-title":"Nucl Med Commun"},{"issue":"7","key":"12684_CR15","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jjco\/hyr062","volume":"41","author":"Y Tsutani","year":"2011","unstructured":"Tsutani Y, Miyata Y, Misumi K, et al. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. Jpn J Clin Oncol. 2011;41(7):890\u20136.","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"12684_CR16","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.jtcvs.2017.08.037","volume":"154","author":"A Hattori","year":"2017","unstructured":"Hattori A, Matsunaga T, Takamochi K, et al. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017;154(6):2102-2110.e2101.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"12684_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jtho.2018.12.030","volume":"14","author":"T Ye","year":"2019","unstructured":"Ye T, Deng L, Wang S, et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype. J Thorac Oncol. 2019;14(4):617\u201327.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"12684_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.athoracsur.2019.01.079","volume":"108","author":"T Miyoshi","year":"2019","unstructured":"Miyoshi T, Aokage K, Katsumata S, et al. Ground-glass opacity is a strong prognosticator for pathologic stage IA lung adenocarcinoma. Ann Thorac Surg. 2019;108(1):249\u201355.","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"12684_CR19","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#","volume":"75","author":"M Noguchi","year":"1995","unstructured":"Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung, Histologic characteristics and prognosis. Cancer. 1995;75(12):2844\u201352.","journal-title":"Cancer"},{"issue":"1","key":"12684_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","volume":"111","author":"K Suda","year":"2021","unstructured":"Suda K, Mitsudomi T, Shintani Y, et al. Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases. Ann Thorac Surg. 2021;111(1):269\u201376.","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"12684_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/JTO.0b013e31826bb7b2","volume":"7","author":"SP D'Angelo","year":"2012","unstructured":"D\u2019Angelo SP, Janjigian YY, Ahye N, et al. Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. J Thorac Oncol. 2012;7(12):1815\u201322.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"12684_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","volume":"60","author":"RJ Ginsberg","year":"1995","unstructured":"Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. lung cancer study group. Ann Thorac Surg. 1995;60(3):615\u201322 (discussion 622\u2013613).","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"12684_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","volume":"6","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan clinical oncology group 0201). J Thorac Oncol. 2011;6(4):751\u20136.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"12684_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ejcts\/ezx296","volume":"53","author":"Y Tsutani","year":"2018","unstructured":"Tsutani Y, Tsubokawa N, Ito M, et al. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2018;53(2):366\u201371.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"12684_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S2213-2600(18)30411-9","volume":"6","author":"NK Altorki","year":"2018","unstructured":"Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB\/Alliance 140503). Lancet Respir Med. 2018;6(12):915\u201324.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"12684_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jjco\/hyp156","volume":"40","author":"K Nakamura","year":"2010","unstructured":"Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802\/WJOG4607L). Jpn J Clin Oncol. 2010;40(3):271\u20134.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"12684_CR27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jtcvs.2020.03.041","volume":"161","author":"EG Chan","year":"2021","unstructured":"Chan EG, Chan PG, Mazur SN, et al. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021;161(5):1639-1648.e1632.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12684-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:05:34Z","timestamp":1672668334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12684-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["12684"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12684-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest associated with this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}